Particulate matter pollution linked to mortality, lower life expectancy in the U.S.

Current concentrations of fine particulate matter pollution, which mostly meet the national ambient air quality standard, are still associated with mortality and loss of life expectancy in the US, with larger impacts in poorer counties, according to a study published July 23 in the open-access journal PLOS Medicine by an international team of researchers from the Center for Air, Climate, and Energy Solutions led by Majid Ezzati of Imperial College London, UK.

Particulate matter pollution linked to mortality, lower life expectancy in the U.S.
Credit: SD-Pictures, Pixabay

Exposure to fine particulate matter pollution (PM2.5) is hazardous to health, and reducing PM2.5 is likely to lower mortality, especially from cardiorespiratory diseases. Yet there is not only resistance to more stringent control of PM2.5, but also attempts to roll back current standards. In the new study, Ezzati and colleagues set out to directly estimate the health and longevity impacts of current PM2.5 concentrations, and the benefits of reductions from 1999 to 2015, nationally and at county level, for the entire contemporary population of the contiguous United States. To do so, they used vital registration and population data with information on sex, age, cause of death and county of residence, as well as statistical models to directly estimate mortality and life expectancy loss.

Even though reductions in PM2.5 since 1999 have lowered mortality in the great majority of counties, PM2.5 pollution in excess of the lowest observed concentration (2.8 μg/m3) was responsible for an estimated 15,612 deaths (95% credible interval 13,248–17,945) in females and for 14,757 deaths (95% credible interval 12,617–16,919) in males. These deaths would lower national life expectancy by an estimated 0.15 years (95% credible interval 0.13–0.17) for women and 0.13 years (95% credible interval 0.11–0.15) for men. The life expectancy loss due to PM2.5 was largest around Los Angeles and in some southern states, such as Arkansas, Oklahoma and Alabama. At any PM2.5 concentration, life expectancy loss was, on average, larger in counties with lower income than in wealthier counties. According to the authors, further lowering PM2.5 pollution is likely to benefit the health of the entire US population, and lower health inequalities.

Source:
Journal reference:

Bennett, J.E. et al. (2019) Particulate matter air pollution and national and county life expectancy loss in the USA: A spatiotemporal analysis. PLOS Medicine. doi.org/10.1371/journal.pmed.1002856.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    PLOS ONE. (2019, July 25). Particulate matter pollution linked to mortality, lower life expectancy in the U.S.. News-Medical. Retrieved on April 25, 2024 from https://www.news-medical.net/news/20190725/Particulate-matter-pollution-linked-to-mortality-lower-life-expectancy-in-the-US.aspx.

  • MLA

    PLOS ONE. "Particulate matter pollution linked to mortality, lower life expectancy in the U.S.". News-Medical. 25 April 2024. <https://www.news-medical.net/news/20190725/Particulate-matter-pollution-linked-to-mortality-lower-life-expectancy-in-the-US.aspx>.

  • Chicago

    PLOS ONE. "Particulate matter pollution linked to mortality, lower life expectancy in the U.S.". News-Medical. https://www.news-medical.net/news/20190725/Particulate-matter-pollution-linked-to-mortality-lower-life-expectancy-in-the-US.aspx. (accessed April 25, 2024).

  • Harvard

    PLOS ONE. 2019. Particulate matter pollution linked to mortality, lower life expectancy in the U.S.. News-Medical, viewed 25 April 2024, https://www.news-medical.net/news/20190725/Particulate-matter-pollution-linked-to-mortality-lower-life-expectancy-in-the-US.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Human genetics evidence predictive of drug development success, study shows